UBS’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$586K Sell
15,273
-355
-2% -$13.1K ﹤0.01% 4106
2014
Q2
$574K Sell
15,628
-5,489
-26% -$199K ﹤0.01% 4081
2014
Q1
$782K Sell
21,117
-228
-1% -$8.4K ﹤0.01% 3745
2013
Q4
$756K Buy
21,345
+1,777
+9% +$59.8K ﹤0.01% 3853
2013
Q3
$638K Buy
19,568
+567
+3% +$18.8K ﹤0.01% 3856
2013
Q2
$590K Buy
+19,001
New +$593K ﹤0.01% 3937

Other funds holding BME

UBS's BME Position: Q3 2014 in Review

UBS reduced its BlackRock Health Sciences Trust (BME) stake by 2.3% in Q3 2014, selling an estimated $13.1K and leaving 15,273 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #4106.

UBS first reported a position in BME in Q2 2013 and has held it in 6 quarters since. The position peaked at $782K in Q1 2014. 29 funds tracked by Wall St. Rank hold BME as of Q3 2014.

  • UBS held 15,273 shares of BlackRock Health Sciences Trust worth $586K as of Q3 2014.
  • UBS sold 355 BlackRock Health Sciences Trust shares in Q3 2014, an estimated $13.1K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4106 holding.
  • UBS first reported a position in BlackRock Health Sciences Trust in Q2 2013 and has held it in 6 quarters since.
  • UBS's BlackRock Health Sciences Trust position peaked at $782K in Q1 2014.
  • 29 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.